Target intelligence / Profile preview

Nucleophosmin 1 pseudogene 13 (NPM1P13)

Target
NPM1P13
Molecular classification
Other (Pseudogene)
01

Overview

Nucleophosmin 1 pseudogene 13 (NPM1P13) is a human genomic locus classified as a pseudogene, showing high sequence similarity to the functional Nucleophosmin 1 (NPM1) gene but not producing a functional protein[5]. There is no evidence of its transcription or translation, nor of any function in health or disease. Its primary significance lies in its potential to be misattributed as the real NPM1 gene, which is an important biomarker and therapeutic target in several cancers, especially acute myeloid leukemia.

02

Mechanism of action

None. No mechanisms of action are described for pseudogenes like NPM1P13.

03

Biological functions

None established. Pseudogenes generally have no protein-coding function, although some pseudogenes may have regulatory roles (e.g., as RNA), but no evidence is published for biological function of NPM1P13
04

Disease associations

None known. There are no direct disease associations for NPM1P13. This contrasts with the functional NPM1 protein, which is well-known in the context of acute myeloid leukemia and other cancers

Beyond the preview

Go deeper on Nucleophosmin 1 pseudogene 13 (NPM1P13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleophosmin 1 pseudogene 13 (NPM1P13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call